Anyone who works out either at the gym or on their own, knows how good it is to get results. It’s no surprise that many people consider taking supplements to enhance their resistance. Bodybuilding supplements, such as Jack3d, allow for the user to work out longer by not wearing down as quickly, ultimately providing for [...]
Late last year Novartis announced termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment; 8,609 patients from 36 countries were involved.
As the world welcomed a new year, on January 1, 2012, The shareholders at Anapol Schwartz welcomed another member to their table. Gregory Spizer a non-equity partner at Anapol Schwartz became an Equity Partner and Firm Shareholder.
In a recent New York Times article, the prescription drug Avandia was cited for causing heart problems in patients taking the medication. Avandia, commonly used for Type 2 Diabetes, was implicated in over 300 deaths in 2009. Also known as, Rosiglitazone, Avandia is also responsible for hundreds of heart attacks and heart failures.
